Focus and Scope
Cardiology Journal is a peer-reviewed journal published since 1994 and over the years it has become an internationally acknowledged journal, mostly due to constantly increasing quality of original papers submitted to the journal from all-over-the-world.
The Journal publishes only high-quality research and review articles, letters to the editors, technology notes, images in cardiovascular medicine, editorial comments, brief communications and study protocols, comprising both clinical and translational investigations in the field of cardiology.
The scope of the Journal covers a broad spectrum of topics in the field of cardiovascular medicine comprising clinical cardiology, heart failure, prevention and rehabilitation, innovation and technology, interventional cardiology, invasive/non-invasive imaging, device failure, arrhythmology, translational research, quality and outcomes.
Cardiology journal is particularly focused on innovation and technology applied to cardiovascular medicine. Original Research on this topic will receive absolute priority, provided that the quality of the manuscript meets the high standards of the journal and can compete fairly with the submissions in other areas. The ultimate mission of the journal is building bridges between technology and clinical research that can be beneficial for patients with cardiovascular disease. In this context, the journal offers Ultrafast review (as explained in the authors’ guidelines) for the following categories of papers in cardiovascular research:
- Methodological papers.
- First-in-man studies of novel devices.
- Original research on device failure.
- Bioengineering models.
- Innovation and technology in the pipeline.
Peer Review Process
Review process and manuscript selection
″Cardiology Journal″ is committed to prompt evaluation and publication of submitted articles. All manuscripts together with supplementary files should be submitted online at www.cardiologyjournal.org. The submission and review process is fully electronic and submissions by e-mail or postal mail will not be accepted. Please follow the manuscript preparation directions presented below. Manuscripts submitted for publication in CJ are evaluated as to whether they present new insights into the announced topic and are likely to contribute to progress in research or to changes in clinical practice. Received manuscripts are initially examined by the Journal editors. Manuscripts with insufficient priority for publication are rejected immediately to allow the authors to recognize deficiencies and submit the paper to another journal or submit a revised version to CJ. Incomplete submissions or manuscripts not prepared in the required style (see ′Preparation of manuscripts′) are sent back to the authors without scientific review. If manuscript is accepted for review, the authors will be notified in the electronic way only with the reference to the article ID number in the electronic system. Articles are evaluated by at least two outside referees who are contacted before being sent a paper and asked to return comments within 3 weeks. All submitted manuscripts are treated as confidential documents, and reviewers are instructed to treat manuscripts as such. The peer review process is also confidential and identities of reviewers are not released (single-blind review). Referees are asked to provide a written review together with recommendation of acceptance, requirement for revision or rejection of the article. Submitted papers are accepted for publication after a positive opinion has been returned by the referees. Authors are notified of decisions by e-mail only. Selected papers are edited to improve accuracy and clarity and for length. Papers submitted to CJ but not accepted for publication may, in some cases, be eligible for publication in other journals of the Publisher.
Reviewers’ criteria for manuscripts qualification
Title reflects the subject undertaken
Assumptions are proper
Work of practical nature
Work of educational nature
Aims are clearly defined
Ethical criteria fulfilled*
Results are adequately presented*
Statistical analysis is reliable*
Discussion refers to results*
Conclusions based on study findings*
Conclusions refer to aims*
Suitably chosen, proper number and up to date references
All figures and tables are required
Standard of written English acceptable
*criteria exclusively for research papers
Manuscripts authored by Editors or members of Editorial Board are treated no differently to any other manuscript submitted to Cardiology Journal. All possible measures are undertaken to avoid any potential conflict of interest in handling of such manuscripts at all the stages including allocation of handling Editor, selection of reviewers, decision making and, if required, processing for publication.
Editors or Editorial Board members may submit their own manuscripts for possible publication in The Journal occasionally, but they are completely excluded from peer–review process and publication decisions when they are authors or co–authors of a manuscript. Manuscripts authored by a member of a journal’s editorial team (editors, Editorial Board members) are independently peer–reviewed and the peer review process is managed by the alternative members of the Editorial Board.
Open Access Policy
This journal provides immediate open access to its on line content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Articles published in open access are available under Creative Common Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
Via Medica (Publisher) self-archiving policy establishes that authors can archive only accepted manuscripts including final PDF version and/or 'ahead of print' in any repository. In details, the author may only post their version provided acknowledgment is given to the original source of publication and a link is inserted to the published article on Via Medica (Publisher) website. Apart from the link mentioned above, the acknowledgment should be provided with the full bibliographic record with DOI number.
Cardiology Journal (CJ) will accept advertising for services and products that are of value to readers in their professions. Distinction between advertising and editorial content should be easy. CJ does not allow advertising to influence editorial decisions. Online advertising or sponsorship should not impede users’ access to editorial content. Journal accepts advertising from competitors. Advertisements or sponsorship related to tobacco products will not be accepted.
Advertisements and sponsorship must be legal, trusthworthy and comply with the relevant industry codes, laws and regulations.
Complaints Handling Policy
This policy applies to complaints on policies, procedures and actions of CJ’s editorial staff and as a rule is regarded as an opportunity for improvement. Complaints will be dealt with by members of the editorial staff, escalating (if required) to editors-in-chief, whose decision is regarded as final. Complaints should be directly emailed to a person indicated as a support contact at the Journal’s contact panel. All complaints will be acknowledged within three working days and, if possible, a full response will be made within three weeks. If this is not possible an interim response will be given within this timeframe. Further responses will be provided until the issue is resolved.
If authors are convinced that the article they submitted was rejected wrongly, they should send rebuttal letter via CJ’s support contact rather than submitting a revised article at this stage. If the editors agree to such appeal, authors may be asked to submit a revised version of the article in question which will enter again into CJ’s review process. The rebuttal letter should be detailed and include responses to comments from external reviewers and from Journal’s editors. Only one appeal per article will be considered. An invitation for resubmission after appealing is by itself not a guarantee of acceptance.
Informed Consent for Publication
To secure release from the responsibilities to the third parties, corresponding author is required to return to the Publisher a singed copy of the ‘Authors' Statement together with the manuscript. All authors must agree to the conditions of publication, however the final responsibility for this information lays on the author submitting the manuscript.
Sharing Research Data
The Journal encourages you to share data that supports your research publication where appropriate. Research data refers to the results of observations or experimentation that validate research findings. If you are sharing data, you are encouraged to cite the data in your manuscript and reference list.
If you have made your research data available in a data repository, you can link your article directly to the dataset thus giving readers access to underlying data that gives them a better understanding of the research described. There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system.
Via Medica recommends the use of Mendeley Data, which enables you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository.